SAN DIEGO, Nov. 1 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. announced today that the Company will report third quarter 2004 financial results after the Nasdaq market closes Monday, November 1, 2004. Neurocrine will also host a live conference call and webcast to discuss the third quarter results and provide a Company update on Monday afternoon, November 1, 2004 at 5:00PM Eastern Standard Time (EST), 2:00PM Pacific Standard Time (PST). Participants may access the live conference call by dialing 1-800-540-0559 (U.S.) or 785-832-1508 (International) providing the Conference ID#: NBIX. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com/ or alternatively at PRNewswire: http://phx.corporate-ir.net/phoenix.zhtml?p=irol- eventDetails&c=68817&eventID=955161
Gary A. Lyons, President and Chief Executive Officer and Paul W. Hawran, Executive Vice President and Chief Financial Officer will present the Company's third quarter 2004 financial results and provide an update on the Company's research and development programs. If you are unable to attend the webcast and would like further information on this announcement please contact Claudia Jones or Elizabeth Foster in the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the conference call will be available approximately one hour after the conclusion of the call by dialing 1-888-276-5316 (US) or 402-220-2333 (International). The call will be archived until Monday, November 15, 2004.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com/
Neurocrine Biosciences, Inc.CONTACT: Claudia Jones or Elizabeth Foster of Neurocrine Biosciences,Inc., +1-858-658-7600
Web site: http://www.neurocrine.com/